Neuronal ceroid lipofuscinosis: Clinical and morphologic findings in nine affected Polish Owczarek Nizinny (PON) dogs

Veterinary Ophthalmology

Volumn 10, Issue 2, 2007, Pages 111-120

  Narfström, Kristina ^a,b   Wrigstad, A ^c   Ekesten, B ^d   Berg, A L ^d,e  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF MISSOURI   (United States)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d SUAS   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

Animal model; Ceroid lipofuscinosis; CLN1; Lysosomal storage disease; Retina; Saposin

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 33847109810     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2007.00527.x     Document Type: Article

References (34)

1. Jolly RD, Palmer DN, Studdert VP et al. Canine ceroid-lipofuscinoses: a review and classification. Journal of Small Animal Practice 1994; 35: 299-306.
2. Jolly RD, Palmer DN. The neuronal ceroid-lipofuscinoses (Batten disease): comparative aspects. Neuropathology and Applied Neurobiology 1995; 21: 50-60.
3. Tyynelä J, Palmer DN, Baumann M et al. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Letters 1993; 330: 8-12.
4. Palmer DN, Tyynelä J, van Mil HC et al. Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis. Journal of Inherited Metabolic Disease 1997; 20: 74-84.
5. Wisniewski KE, Kida E, Golabek AA et al. Neuronal ceroid lipofuscinosis: classification and diagnosis. In: Batten Disease: Diagnosis, Treatment, and Research. (eds Wisniewski KE, Zhong N) Academic Press Inc., New York, 2001; 1-34.
6. Katz ML, Khan S, Awano T et al. A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis. Biochemical and Biophysical Research Communications 2005; 327: 541-547.
7. Evans J, Katz ML, Levesque D et al. A variant form of neuronal ceroid lipofuscinosis in American Bulldogs. Journal of Veterinary International Medicine 2005; 19: 44-51.
8. Melville SA, Wilson CL, Chiang CS et al. A mutation in the canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs. Genomics 2005; 86: 287-294.
9. Awano T, Katz ML, O'Brien DP et al. A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. Molecular Genetics and Metabolism in press.
10. Katz ML, Narfström K, Johnson GS et al. Assessment of retinal function and characterization of lysosomal storage body accumulation in the retinas and brains of Tibetan Terriers with ceroid-lipofuscinosis. American Journal of Veterinary Research 2005; 66: 67-76.
11. Drogemuller C, Wohlke A, Distl O. Evaluation of the canine TPP1 gene as a candidate for neuronal ceroid lipofuscinosis in Tibetan Terrier and Polish Owczarek Nizinny dogs. Animal Genetics 2005; 36: 178-179.
12. Wrigstad A, Nilsson SEG, Dubielzig R et al. Neuronal ceroid lipofuscinosis in the Polish Owczarek Nizinny (PON) dog. Documenta Ophthalmologica 1995; 91: 33-47.
13. Narfström K, Andersson B-E, Andreasson S et al. Clinical electroretinography in the dog with Ganzfeld stimulation: a practical method of examining rod and cone function. Documenta Ophthalmologica 1995; 90: 279-290.
14. Narfström K, Ekesten B. Electroretinographic evaluation of Papillons with and without hereditary retinal degeneration. American Journal of Veterinary Research 1998; 59: 221-226.
15. Narfström K, Ekesten B, Rosolen SG et al. Guidelines for clinical electroretinography in the dog. Documenta Ophthalmologica 2002; 105: 83-92.
16. Sleat DE, Wiseman JA, El-Banna M et al. A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. Journal of Neuroscience 2004; 24: 9117-9126.
17. Smith RIE, Sutton RH, Jolly RD et al. A retinal degeneration associated with ceroid-lipofuscinosis in adult miniature Schnauzers. Veterinary and Comparative Ophthalmology 1996; 6: 187-191.
18. Tyynelä J, Suopanki J. Biochemical aspects of neuronal ceroid lipofuscinoses. Neurological Sciences 2000; 21: S21-S25.
19. Morimoto S, Yamamoto Y, O'Brien JS et al. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Proceedings of the National Academy of Science USA 1990; 87: 3493-3497.
20. Aguirre G, Laties A. Pigment epithelial dystrophy in the dog. Experimental Eye Research 1976; 23: 247-256.
21. Bedford PGC. Retinal pigment epithelial cell dystrophy (CPRA): a study of the disease in the Briard. Journal of Small Animal Practice 1984; 25: 129-138.
22. Riis R, Sheffy BE, Loew TJ et al. Vitamin E deficiency retinopathy in dogs. American Journal of Veterinary Research 1981; 42: 74-86.
23. Robinson WG, Kuwabara T, Bieri JG. Vitamin E deficiency and the retina: photoreceptor and retinal pigment epithelial changes. Investigative Ophthalmology and Visual Science 1979; 18: 683-690.
24. Katz ML, Parker KR, Handelman GL et al. Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Experimental Eye Research 1982; 34: 339-369.
25. Hayes KC. Retinal degeneration in monkeys induced by deficiencies of vitamin E and A. Investigative Ophthalmology 1974; 13: 499-510.
26. Davidson MG, Geoly EJ, Gilger BC et al. Retinal degeneration associated with vitamin E deficiency in hunting dogs. Journal of the American Veterinary Medical Association 1998; 213: 645-651.
27. Saari JS. Biochemistry of visual pigment regeneration. Investigative Ophthalmology and Visual Science 2000; 41: 337.
28. Roman AJ, Schwartz SB, Aleman TS et al. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Experimental Eye Research 2005; 80: 259-272.
29. Niwa Y, Kondo M, Ueno S et al. Cone and rod dysfunction in fundus albipunctatus with RDH5 mutation: An electrophysiological study. Investigative Ophthalmology and Visual Science 2005; 56: 1480-1485.
30. Weleber RG. The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuchsinoses. Eye 1998; 12: 580-590.
31. Semo M, Peirson S, Lupi D et al. Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary responses to light in aged rodless/coneless (rd/rd cl) mice. European Journal of Neuroscience 2003; 17: 1793-1801.
32. Greer KA, Cargill EJ, Cox ML et al. Digging up the canine genome - a tale to wag about. Cytogenic and Genome Research 2003; 102: 244-248.
33. Acland GM, Aguirre GD, Ray J et al. Gene therapy restores vision in a canine model of childhood blindness. Nature Genetics 2001; 28: 92-95.
34. Narfström K, Katz M, Bragadottir R et al. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Investigative Ophthalmology and Visual Science 2003; 44: 1663-1672.